Anaplastic thyroid carcinoma: An overview

被引：73

作者：

Cornett W.R. ^{[1
]}

Sharma A.K. ^{[1
]}

Day T.A. ^{[1
]}

Richardson M.S. ^{[1
]}

Hoda R.S. ^{[1
]}

van Heerden J.A. ^{[1
]}

Fernandes J.K. ^{[1
]}

机构：

[1] The Medical University of South Carolina, Charleston, SC 29425

来源：

Current Oncology Reports | 2007年 / 9卷 / 2期

关键词：

Thyroid Cancer; Thyroid Carcinoma; Neck Dissection; Recurrent Laryngeal Nerve; Total Thyroidectomy;

D O I：

10.1007/s11912-007-0014-3

中图分类号：

学科分类号：

摘要：

Thyroid cancer is an uncommon malignancy that accounts for roughly 1% of all new cancer. Although anaplastic lesions constitute fewer than 5% of thyroid cancers, they represent over half of thyroid cancer-related deaths. The relative rarity of anaplastic thyroid cancer, its aggressive nature, and its rapidly fatal course have contributed to the difficulty in developing effective treatment for this disease. Radiation, chemotherapy, and surgery are rarely curative, but combinations of these modalities appear to offer greater benefit than any single treatment. New treatment modalities are desperately required, and promising molecular-based therapies are being investigated. Copyright © 2007 by Current Medicine Group LLC.

引用

页码：152 / 158

页数：6

共 39 条

[31]

Pallante P., Berlingieri M.T., Troncone G., Et al., UbcH10 overexpression may represent a marker of anaplastic thyroid carcinomas, Br J Cancer, 93, pp. 464-471, (2005)

[32]

Mizutani K., Onda M., Asaka S., Et al., Overexpressed in anaplastic thyroid carcinoma-1 (OEATC-1) as a novel gene responsible for anaplastic thyroid carcinoma, Cancer, 103, pp. 1785-1790, (2005)

[33]

Nobuhara Y., Onoda N., Yamashita Y., Et al., Efficacy of epidermal growth factor receptor-targeted molecular therapy in anaplastic thyroid cancer cell lines, Br J Cancer, 92, pp. 1110-1116, (2005)

[34]

Younes M.N.K.S., Yigitbasi O.G., Mandal M., Et al., Integrin-linked kinase is a potential therapeutic target for anaplastic thyroid cancer, Mol Cancer Ther, 4, pp. 1146-1156, (2005)

[35]

Sorrentino R., Libertini S., Pallante P.L., Et al., Aurora B overexpression associates with the thyroid carcinoma undifferentiated phenotype and is required for thyroid carcinoma cell proliferation, J Clin Endocrinol Metab, 90, pp. 928-935, (2005)

[36]

Nikiforov Y.E., Editorial: Anaplastic carcinoma of the thyroid-Will aurora B light a path for treatment?, J Clin Endocrinol Metab, 90, pp. 1243-1245, (2005)

[37]

Zhong W.B., Liang Y.C., Wang C.Y., Et al., Lovastatin suppresses invasiveness of anaplastic thyroid cancer cells by inhibiting Rho geranylgeranylation and RhoA/ROCK signaling, Endocr Relat Cancer, 12, pp. 615-629, (2005)

[38]

Bulgin D.P.A., Takakura S., Mitsutake N., Et al., Selective pharmacologic inhibition of c-Jun NH2-terminal kinase radiosensitizes thyroid anaplastic cancer cell lines via induction of terminal growth arrest, Thyroid, 16, pp. 217-224, (2006)

[39]

Moscetti L., Padalino D., Capomolla E., Et al., A partial response in anaplastic carcinoma of the thyroid with liposomal doxorubicin, J Exp Clin Cancer Res, 24, pp. 151-154, (2005)

← 1 2 3 4 →